159 (PB039) - A combination vertical inhibition approach with inhibitors of SHP2 and ERK provides improved activity in KRAS-mutant pancreatic and colorectal cancer models
- Resource Type
- Abstract
- Source
- In
European Journal of Cancer October 2022 174 Supplement 1:S57-S57 - Subject
- Language
- ISSN
- 0959-8049